GlassScriptPhysician profile
Carly H Davis
NPI 1417116062
$831.16
in general payments reported to CMS, 2019-2025
19 companies · $46.45 in 2025
The $46.45 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $23.73 · 2021: $163 · 2022: $40.41 · 2023: $167 · 2024: $233 · 2025: $46.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $445.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $151.23 | 2019-2023 | Myosure Tissue Removal Device |
| Abbvie INC. | $122.23 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Exeltis, USA INC. | $85.73 | 2024-2025 | Slynd |
| Aspira Women'S Health INC | $83.59 | 2024 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $78.98 | 2020-2024 | |
| Merck Sharp & Dohme LLC | $43.87 | 2021-2023 | Gardasil 9 |
| Pfizer INC. | $40.12 | 2019-2024 | |
| Astellas Pharma US INC | $39.25 | 2024-2025 | Veozah |
| Biohaven Pharmaceuticals, INC. | $23.67 | 2021 | |
| Daiichi Sankyo INC. | $22.98 | 2023 | Injectafer |
| Organon LLC | $19.49 | 2024 | |
| Axonics, INC. | $19.46 | 2023 | Axonics |
| Glaxosmithkline, LLC. | $16.90 | 2019 | |
| Avion Pharmaceuticals | $16.75 | 2021 | |
| Myovant Sciences INC. | $16.41 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $13.91 | 2024 | Prevena |
| Lupin INC. | $13.05 | 2019 | |
| Allergan, INC. | $12.65 | 2020 | |
| Kci USA, INC. | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carly Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.